Accelerating Life Sciences R&D With Pega

Despite huge scientific advances and new technologies, biopharma R&D has been struggling for decades. The average annual output of approved new products per major pharmaceutical company had remained relatively flat for nearly 60 years – irrespective of the company’s size or level of R&D investment. Learn how industry leaders rely on Pega to change the game by connecting end-to-end lab data workflows, making clinical trials more efficient, reducing risk, and operationalizing quality management – to revolutionize R&D operations.


Related Resources

PegaWorld 2019

Registration is now open

Hear how remarkable brands are leveraging Pega technology to transform their business.

Pega Infinity

Pega Infinity™

We’ve brought together customer engagement and digital process automation in one unified portfolio, powered by our visionary no-code platform.